Nicholas Khadder Standard Biotools Inc. (LAB) insider trading activity

Nicholas Khadder is SVP, Gen. Counsel & Secretary of STANDARD BIOTOOLS INC.. Currently has a direct ownership of 100,480 shares of LAB, which is worth approximately $200,960. The most recent transaction as insider was on May 31, 2022, when has been sold 3,341 shares (Common Stock) at a price of $1.61 per share, resulting in proceeds of $5,379. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K

0% 3M change

0% 12M change

Total Value Held $200,960

Nicholas Khadder Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2022	BUY Grant, award, or other acquisition	$5,379 $1.61 p/Share	3,341 Added 3.22%	100,480 Common Stock
May 20 2022	SELL Payment of exercise price or tax liability	-	14,161 Reduced 12.72%	97,139 Common Stock
May 20 2022	BUY Exercise of conversion of derivative security	-	28,909 Added 20.62%	111,300 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$8,214 $3.62 p/Share	2,269 Reduced 2.68%	82,391 Common Stock
Feb 22 2022	BUY Exercise of conversion of derivative security	-	4,062 Added 4.58%	84,660 Common Stock
Nov 20 2021	SELL Payment of exercise price or tax liability	$9,043 $4.49 p/Share	2,014 Reduced 2.48%	79,235 Common Stock
Nov 20 2021	BUY Exercise of conversion of derivative security	-	4,063 Added 4.76%	81,249 Common Stock
Aug 20 2021	SELL Payment of exercise price or tax liability	$13,145 $6.53 p/Share	2,013 Reduced 2.54%	77,186 Common Stock
Aug 20 2021	BUY Exercise of conversion of derivative security	-	4,062 Added 4.88%	79,199 Common Stock
May 20 2021	SELL Payment of exercise price or tax liability	$126,066 $5.52 p/Share	22,838 Reduced 23.56%	74,080 Common Stock
May 20 2021	BUY Exercise of conversion of derivative security	-	46,250 Added 32.3%	96,918 Common Stock

Also insider at

COO

COOPER COMPANIES, INC. Healthcare

VP, General Counsel & Corp Sec